Article
A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns.
PloS one - 30 Jul 2009
ter Veld Frank, Mueller Martina, Kramer Simone, Haussmann Ulrike, Herebian Diran, Mayatepek Ertan, Laryea Maurice D, Primassin Sonja, Spiekerkoetter Ute
Abstract excerpt
BACKGROUND: Newborn screening for medium- and very long-chain acyl-CoA dehydrogenase (MCAD and VLCAD, respectively) deficiency, using acylcarnitine profiling with tandem mass spectrometry, has increased the number of patients with fatty acid oxidation disorders due to the identification of additional milder, and so far silent, phenotypes. However, especially for VLCADD, the acylcarnitine profile can not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
